Proto Indo-European: Echoes of History youtube.com/shorts/UeeJV5W-5… via @YouTube
Rob Fried retweeted
NAD+ support isn’t one-size-fits-all. Unlike traditional NAD+ IVs that take hours, Niagen Plus delivers nicotinamide riboside (NR), a patented precursor the body converts into NAD+. No long infusions. A more convenient way to support NAD+ and cellular health.
New study suggests remote, personalized exercise training can safely improve fitness in individuals with Friedreich’s Ataxia | Children's Hospital of Philadelphia chop.edu/news/new-study-sugg…
Rob Fried retweeted
Niagen team gave 135 IV infusions in 48 hours at the sold-out All-In Liquidity Summit in Yountville. The event brought together leaders in business and technology, with strong interest in recovery, resilience, and proactive approaches to cellular health.
What is a USP Monograph and What Does It Mean for NRCl? | AboutNAD aboutnad.com/blogs/blog/nico…
Rob Fried retweeted
Replying to @latterddssaint @CharlesMBrenner
Ask Charles he’s the expert. I know the pathways and have read the papers but he’s the expert on this.
Rob Fried retweeted
suggestions of positive activity for Niagen NR in long COVID in improving sleep quality & executive function, & reducing fatigue & depression
sciencedirect.com/science/ar…
#RCT
6 Steps To Preserve Brain Health Now To Prevent Dementia As You Age forbes.com/sites/bryanrobins…
Vogue’s Guide to the Best NAD+ Supplements | Vogue vogue.com/article/best-nad-s…
2024 was a seminal year for Chromadex, for Tru Niagen and for NAD science . Congratulations and thank you , once again, to the dedicated and smart working team, partners , investors, researchers, regulators and consumers who contributed to a record year @chromadex@truniagen
We can take high resolution images of galaxies predating the Big Bang yet cannot get an image of a drone flying 1000 feet above New Jersey? #drones
Is Nicotinamide Riboside the Future of Anti-Aging? longevity.technology/lifesty…
Rob Fried retweeted
We appreciate you highlighting our team's work and sharing this release:
.@ChromaDex announces promising findings from 2 independent clinical study abstracts originally presented at #ARVO2023. Results suggest #glaucoma patients have lower cellular NAD+ levels & replenishing levels with a precursor, like NR, may be a strategy. bit.ly/44MQyF0
Natural dietary supplement for the successful treatment of Alzheimer’s disease ustoday.news/natural-dietary…













